PropertyValue
is ?:annotates of
?:creator
?:journal
  • Eur_Heart_J
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the \'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19\'
?:type
?:who_covidence_id
  • #939564
?:year
  • 2020

Metadata

Anon_0  
expand all